Search - tctmd.com

Displaying 261 - 280 of 349

Sort: Relevancy | Date

Presentation TCT 2014

Use of OCT to Evaluate Stent Failures (Thrombosis and Restenosis)

Presenter: Robert S. Schwartz, Ron Waksman, Jorge F. Saucedo, Evelyn S. Regar

September 14, 2014

Presentation TCT 2014

DCB ONLY and Vascular Restoration: Insights from Intracoronary OCT Human Studies

Presenter: Robert A. Byrne, Bruno Scheller, Francesco Liistro, Tudor C Poerner

September 13, 2014

News Daily News

PROTECT: Menor Riesgo de Trombosis del Stent con el Endeavor a los 4 Años

L.A. McKeown

September 02, 2014

News Daily News

PROTECT: Lower Stent Thrombosis Risk with Endeavor Emerges at 4 Years

L.A. McKeown

September 02, 2014

News Daily News

El Impacto Clínico del Fracaso del SLF Depende del Timing

L.A. McKeown

August 07, 2014

News Daily News

Clinical Impact of DES Failure Depends on Timing

L.A. McKeown

August 07, 2014

Presentation BRS 2014

How to Size BRS? Visual Angio, QCA, IVUS, OCT or Other

Presenter: Y. Onuma

July 25, 2014

News Daily News

Un Stent Recubierto de una Malla resulta Seguro en Pacientes STEMI aunque el Riesgo de RLD, RVD es Mayor que con los SMD

July 08, 2014

News Daily News

Mesh-Covered Stent Safe in STEMI Patients but Risk of TLR, TVR Higher vs BMS

July 08, 2014

News Conference News EuroPCR 2014

Despite Some Good News, Dedicated Stents Fail to Surpass Standard Care for Bifurcation Lesions

Caitlin E. Cox

May 20, 2014

News Daily News

DUTCH PEERS Published: Third-Generation Zotarolimus, Everolimus Stents Equivalent

February 12, 2014

News Daily News

DUTCH PEERS Publicado: Los Stents liberadores de Zotarolimus y Everolimus de 3ª Generación son Equivalentes

February 12, 2014

News Daily News

Stent Malapposition Frequent, But Without Clinical Consequences

Jason Kahn

January 27, 2014

News Daily News

La Mala Aposición del Stent es algo Frecuente que No tiene Consecuencias Clínicas

Jason Kahn

January 27, 2014

Presentation

Incidences, Predictors, and Clinical Outcomes of Stent Malapposition Detected by OCT After DES

Presenter: E. Im

January 26, 2014

News Daily News

Meta-analysis: Newer-Generation DES Safe, Effective vs. BMS in STEMI

January 01, 2014

News Daily News

Meta Análisis: Comparados con los SMD, los SLF de Última Generación son Seguros y Eficaces contra los cuadros de STEMI

January 01, 2014

News Daily News

Un Análisis Revela que, comparados con los SMD, los SLF Reducen la RVD pero No la Mortalidad en Pacientes Muy Ancianos

December 30, 2013

News Daily News

Analysis Shows DES Reduce TVR but Not Mortality vs. BMS in Extreme Elderly

December 30, 2013

Presentation TCT 2013

Drug-Coated Balloon Mechanisms of Action: Insights From Angiography, FFR and OCT

Presenter: Pierfrancesco Agostoni

October 31, 2013

Advertisement

Use of OCT to Evaluate Stent Failures (Thrombosis and Restenosis)

DCB ONLY and Vascular Restoration: Insights from Intracoronary OCT Human Studies

PROTECT: Menor Riesgo de Trombosis del Stent con el Endeavor a los 4 Años

PROTECT: Lower Stent Thrombosis Risk with Endeavor Emerges at 4 Years

El Impacto Clínico del Fracaso del SLF Depende del Timing

Clinical Impact of DES Failure Depends on Timing

How to Size BRS? Visual Angio, QCA, IVUS, OCT or Other

Un Stent Recubierto de una Malla resulta Seguro en Pacientes STEMI aunque el Riesgo de RLD, RVD es Mayor que con los SMD

Mesh-Covered Stent Safe in STEMI Patients but Risk of TLR, TVR Higher vs BMS

Despite Some Good News, Dedicated Stents Fail to Surpass Standard Care for Bifurcation Lesions

DUTCH PEERS Published: Third-Generation Zotarolimus, Everolimus Stents Equivalent

DUTCH PEERS Publicado: Los Stents liberadores de Zotarolimus y Everolimus de 3ª Generación son Equivalentes

Stent Malapposition Frequent, But Without Clinical Consequences

La Mala Aposición del Stent es algo Frecuente que No tiene Consecuencias Clínicas

Incidences, Predictors, and Clinical Outcomes of Stent Malapposition Detected by OCT After DES

Meta-analysis: Newer-Generation DES Safe, Effective vs. BMS in STEMI

Meta Análisis: Comparados con los SMD, los SLF de Última Generación son Seguros y Eficaces contra los cuadros de STEMI

Un Análisis Revela que, comparados con los SMD, los SLF Reducen la RVD pero No la Mortalidad en Pacientes Muy Ancianos

Analysis Shows DES Reduce TVR but Not Mortality vs. BMS in Extreme Elderly

Drug-Coated Balloon Mechanisms of Action: Insights From Angiography, FFR and OCT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content